Page last updated: 2024-11-07

methylprednisolone acetate and Syndrome, VKH (Vogt Koyanagi Harada)

methylprednisolone acetate has been researched along with Syndrome, VKH (Vogt Koyanagi Harada) in 1 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bennett, FM1

Other Studies

1 other study available for methylprednisolone acetate and Syndrome, VKH (Vogt Koyanagi Harada)

ArticleYear
VOGT-KOYANAGI DISEASE.
    The British journal of ophthalmology, 1962, Volume: 46, Issue:9

    Topics: Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Methylprednisolone; Methylprednis

1962